MeiraGTx Holdings plc
NASDAQ:MGTXBiotechnology
+$0.53 today
- Market cap
- $813.12M
- Beta
- 1.26
- P/E (TTM)
- -7.4
- EPS (TTM)
- -$1.48
Volume 0.58M
Average 0.84M
MGTX Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
MeiraGTx Holdings plcNASDAQ: MGTX
Net Margin · Q1 FY2026 · quarter ended Mar 2026
Net margin narrows to -15806.5%
Net margin was -15806.5% in Q1 FY2026, down 13730.6 pp from a year earlier. On a trailing-twelve-month basis it was -151.1%, up 333.8 pp year over year. Over 3 fiscal years it widened by 673.9 pp.
Context
- Net margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether net margin reaches the consensus estimate from 5 analysts of 6.7% for the fiscal year ending Dec 2026, up from -140.3% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -15806.5%-15826.5 pp QoQ
- Last fiscal yearDec 2025
- -140.3%+303.8 pp YoY
- LTMMar 2026
- -151.1%+333.8 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -140.3%
- Year-over-year change
- +303.8pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -140.3% | +303.8pp |
| FY2024 | 2024-12-31 | -444.1% | +155.4pp |
| FY2023 | 2023-12-31 | -599.5% | +214.7pp |
| FY2022 | 2022-12-31 | -814.2% | -603.1pp |
| FY2021 | 2021-12-31 | -211.0% | — |
Net Margin vs competitors
How MGTX compares with its peers on the latest reported figures
- MGTX's LTM Mar 2026 net margin of -151.1% is the 2nd highest of the 8 companies compared; the peer median is -434.4%.
- Its year-over-year change of +333.8 pp is the 3rd highest of 8, against a peer median of -77.4 pp.
- Over three fiscal years its change of +673.9 pp compares with a peer median of +217.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 54.8% | +14.0 pp | — | |
| LTM Mar 2026 | -151.1% | +333.8 pp | +673.9 pp | |
| LTM Mar 2026 | -182.3% | +766943.8 pp | +3271.0 pp | |
| LTM Mar 2026 | -330.2% | -229.6 pp | +134.9 pp | |
| LTM Mar 2026 | -434.4% | -264.9 pp | -257.8 pp | |
| LTM Mar 2026 | -597.0% | +557.1 pp | +299.9 pp | |
| LTM Mar 2026 | -1154.4% | -77.4 pp | -1116.9 pp | |
| LTM Mar 2026 | -1605.2% | -334.1 pp | +1951.5 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding MGTX) | -434.4% | -77.4 pp | +217.4 pp | |
Competitors are the stored peer set for MGTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 37.7M | 15.92M | 14.02M | 33.28M | 81.39M |
| Cost of Revenue | 0 | 0 | 0 | 23.79M | 4.84M |
| Gross Profit | 37.7M | 15.92M | 14.02M | 9.49M | 76.55M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 28.5% | 94.0% |
| Research & Development | 66.69M | 85.73M | 103.79M | 119.48M | 129.62M |
| Selling, General & Admin | 43.77M | 46.55M | 47.29M | 54.22M | 52.9M |
| Operating Expenses | 110.46M | 132.28M | 151.08M | 173.7M | 182.52M |
| Depreciation & Amortization | 7.87M | 8.6M | 13.73M | 12.83M | 12.61M |
| EBITDA | (71.4M) | (116.07M) | (57.05M) | (121.69M) | (89.4M) |
| EBITDA Margin | -189.4% | -729.1% | -407.0% | -365.7% | -109.8% |
| Operating Income | (72.76M) | (116.36M) | (137.06M) | (164.21M) | (105.97M) |
| Operating Margin | -193.0% | -730.9% | -977.8% | -493.4% | -130.2% |
| Interest Income | 212K | 777K | 2.27M | 4.15M | 1.82M |
| Interest Expense | 288K | 4.95M | 13.25M | 13.27M | 12.2M |
| Other Income / Expenses | (6.8M) | (13.26M) | 53.03M | 16.42M | (8.23M) |
| Income Before Tax | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Pre-Tax Margin | -211.0% | -814.2% | -599.5% | -444.1% | -140.3% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Net Margin | -211.0% | -814.2% | -599.5% | -444.1% | -140.3% |
| EPS (Basic) | (1.80) | (2.87) | (1.49) | (2.12) | (1.42) |
| EPS (Diluted) | (1.80) | (2.87) | (1.49) | (2.12) | (1.42) |
| Weighted Avg Shares | 44.14M | 45.18M | 56.49M | 69.82M | 80.43M |
| Weighted Avg Shares (Diluted) | 44.14M | 45.18M | 56.49M | 69.82M | 80.43M |
MeiraGTx Holdings plc
NASDAQ:MGTX
Intrinsic Alpha fair value
Locked
Current Price
$8.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.